Robotic pancreaticoduodenectomy shows benefits over laparoscopic approach

In a systematic review of eight studies involving 6,648 patients, robotic pancreaticoduodenectomy (RPD) demonstrated significant advantages over laparoscopic pancreaticoduodenectomy (LPD) for malignant lesions. Key findings included a reduced length of hospitalization (mean difference of -0.94 days), lower conversion rates (odds ratio of 0.20), and a higher number of harvested lymph nodes (mean difference of 1.02). Overall morbidity was also lower in the RPD group (odds ratio of 0.50), although some outcomes showed no significant differences.